NETCast cover image

Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies

NETCast

00:00

Novel Targets and Oncolytic Virus Trial

Aman Chauhan highlights targets like TROP2 and the Seneca Valley virus trial leveraging TEM8 to sensitize NECs to immunotherapy.

Play episode from 27:43
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app